Patents Assigned to Imunami Laboratories Pte. Ltd.
  • RECOMBINANT POLYPEPTIDES AND METHODS FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20210393741
    Abstract: The present disclosure provides methods of preventing, delaying the progression of, treating or alleviating a symptom of, or otherwise ameliorating cancer in a subject by administering a recombinant polypeptide, an immune cell growth factor (e.g. FLT3L), a TNFa inhibitory agent (e.g. TNF alpha receptor), an IL-10 inhibitory agent (e.g. Interferon gamma) and/or an immunotherapy agent (e.g. anti-PD-1 antibody) to a subject in need thereof.
    Type: Application
    Filed: June 22, 2020
    Publication date: December 23, 2021
    Applicant: Imunami Laboratories Pte. Ltd.
    Inventors: Ya-Huei CHEN, Ting-long LIN
  • Recombinant polypeptides and methods of use thereof
    Patent number: 10675332
    Abstract: The present disclosure provides methods of preventing, delaying the progression of, treating or alleviating a symptom of, or otherwise ameliorating cancer in a subject by administering a recombinant polypeptide and an agent that reduces IL-10 to a subject in need thereof.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: June 9, 2020
    Assignee: Imunami Laboratories Pte. Ltd.
    Inventors: Ya-Huei Chen, Ting-long Lin
  • Recombinant polypeptides and methods of use thereof
    Patent number: 10370421
    Abstract: The present disclosure provides recombinant polypeptides, nucleic acids encoding the recombinant polypeptides and methods for using these polypeptides and/or nucleic acids in enhancing or inducing an immune response in a subject in need thereof. The present disclosure also provides methods of treating a cell proliferative disorder, such as cancer, by administering the disclosed polypeptides and/or nucleic acids to a subject in need thereof.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: August 6, 2019
    Assignee: Imunami Laboratories Pte. Ltd.
    Inventors: Ya-Huei Chen, Ting-Long Lin
  • Recombinant polypeptides and methods of use thereof
    Patent number: 10351607
    Abstract: The present disclosure provides recombinant polypeptides, nucleic acids encoding the recombinant polypeptides and methods for using these polypeptides and/or nucleic acids in enhancing or inducing an immune response in a subject in need thereof. The present disclosure also provides methods of treating a cell proliferative disorder, such as cancer, by administering the disclosed polypeptides and/or nucleic acids to a subject in need thereof.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: July 16, 2019
    Assignee: Imunami Laboratories Pte. Ltd.
    Inventors: Ya-Huei Chen, Ting-Long Lin
  • Recombinant polypeptides and methods of use thereof
    Patent number: 10323071
    Abstract: The present disclosure provides recombinant polypeptides, nucleic acids encoding the recombinant polypeptides and methods for using these polypeptides and/or nucleic acids in enhancing or inducing an immune response in a subject in need thereof. The present disclosure also provides methods of treating a cell proliferative disorder, such as cancer, by administering the disclosed polypeptides and/or nucleic acids to a subject in need thereof.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: June 18, 2019
    Assignee: Imunami Laboratories Pte. Ltd.
    Inventors: Ya-Huei Chen, Ting-Long Lin
  • Recombinant polypeptides and methods of use thereof
    Patent number: 10301364
    Abstract: The present disclosure provides recombinant polypeptides, nucleic acids encoding the recombinant polypeptides and methods for using these polypeptides and/or nucleic acids in enhancing or inducing an immune response in a subject in need thereof. The present disclosure also provides methods of treating a cell proliferative disorder, such as cancer, by administering the disclosed polypeptides and/or nucleic acids to a subject in need thereof.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: May 28, 2019
    Assignee: Imunami Laboratories Pte. Ltd.
    Inventors: Ya-Huei Chen, Ting-Long Lin
  • Recombinant polypeptides and methods of use thereof
    Patent number: 10150801
    Abstract: The present disclosure provides recombinant polypeptides, nucleic acids encoding the recombinant polypeptides and methods for using these polypeptides and/or nucleic acids in enhancing or inducing an immune response in a subject in need thereof. The present disclosure also provides methods of treating a cell proliferative disorder, such as cancer, by administering the disclosed polypeptides and/or nucleic acids to a subject in need thereof.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: December 11, 2018
    Assignee: Imunami Laboratories Pte. Ltd.
    Inventors: Ya-Huei Chen, Ting-Long Lin